StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5
Publishing Date
2023 - 02 - 13
1
2023 - 01 - 09
1
2022 - 01 - 05
2
2021 - 05 - 19
1
Sector
Health technology
5
Tags
Aacr journals
1
Agreement
1
Als
1
Analytics
2
Annual needham
1
Annual needham virtual healthcare conference
1
Antibody
6
Application
6
Asco
1
Association
1
Biopharma
55
Bn301
1
Business
1
Cancer
10
Care
1
Ceo
3
Ces
1
China
2
Collaboration
4
Commercialization
1
Conference
32
Contract
8
Covid-19
1
Drug
6
Ev
2
Expansion
4
Financial
2
Financial results
3
Germany
1
Grant
3
Granted
1
Grants
4
Health
4
Immunology
3
Immunotherapy
1
License
1
Life
1
Life science
1
Medical
1
Meeting
7
Milestone
6
Molecular
1
N/a
164
Nasdaq
5
Needham virtual healthcare conference
1
Ovarian cancer
5
Partnership
1
Phase 1
5
Phase 2
2
Phase 3
2
Presentation
27
Program
1
Research
17
Results
3
Sciences
1
Stro-002
9
Study
2
Thc
3
Treatment
3
Update
3
Entities
Sutro biopharma, inc.
5
Vaxcyte, inc.
1
Symbols
PCVX
1
STRO
5
Exchanges
Nasdaq
5
Crawled Date
2023 - 02 - 13
1
2023 - 01 - 09
1
2022 - 01 - 06
2
2021 - 05 - 19
1
Crawled Time
10:00
2
17:00
1
21:00
1
22:00
1
Source
alzamend.com
2
investors.biomarin.com
4
ir.anaptysbio.com
1
ir.ateapharma.com
2
ir.benitec.com
2
ir.biolinerx.com
2
ir.hoththerapeutics.com
3
ir.kalvista.com
2
ir.pulmatrix.com
1
ir.stockpr.com
1
ir.vaccinex.com
2
mindmed.co
1
nouveaumonde.ca
2
ocutx.gcs-web.com
1
www.affimed.com
1
www.agtc.com
3
www.alnylam.com
2
www.appliedmt.com
1
www.aquestive.com
1
www.athira.com
1
www.atossatherapeutics.com
1
www.ayalapharma.com
1
www.biospace.com
707
www.celyad.com
3
www.crinetics.com
3
www.curevac.com
3
www.cytomx.com
1
www.diffusionpharma.com
1
www.evelobio.com
1
www.fsdpharma.com
4
www.globenewswire.com
405
www.igcinc.us
5
www.igmbio.com
2
www.immatics.com
2
www.immunogen.com
1
www.nantkwest.com
1
www.nwpipe.com
1
www.oramed.com
1
www.poseida.com
3
www.prnewswire.com
87
www.rubiustx.com
4
www.sutrobio.com
5
www.vbivaccines.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Phase 1
source :
Www.sutrobio.com
save search
BioNova Announces First Patient Dosed in a Phase 1/2 Study of BN301 for the Treatment of Hematologic Malignancies in China
Published:
2023-02-13
(Crawled : 17:00)
- sutrobio.com
STRO
M
|
$3.715
-1.46%
120K
|
Health Technology
|
-40.63%
|
O:
-0.31%
H:
8.62%
C:
-1.88%
bn301
treatment
china
study
phase 1
Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer
Published:
2023-01-09
(Crawled : 22:00)
- sutrobio.com
PCVX
|
$60.72
0.17%
150K
|
Health Technology
|
35.95%
|
O:
-0.3%
H:
1.79%
C:
0.35%
STRO
M
|
$3.715
-1.46%
120K
|
Health Technology
|
-54.16%
|
O:
1.93%
H:
0.89%
C:
-14.08%
stro-002
biopharma
update
cancer
study
ovarian cancer
phase 1
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
Published:
2022-01-05
(Crawled : 10:00)
- sutrobio.com
STRO
M
|
$3.715
-1.46%
120K
|
Health Technology
|
-73.92%
|
O:
-20.18%
H:
0.0%
C:
-9.63%
stro-002
biopharma
expansion
ovarian cancer
phase 1
cancer
2022 KOL Discussion of STRO-002 Phase 1 Interim Dose Expansion Data – Presentation
Published:
2022-01-05
(Crawled : 10:00)
- sutrobio.com
STRO
M
|
$3.715
-1.46%
120K
|
Health Technology
|
-73.92%
|
O:
-20.18%
H:
0.0%
C:
-9.63%
stro-002
expansion
presentation
phase 1
phase 2
phase 3
Sutro Biopharma Announces Additional Data for Dose-Escalation Phase 1 Study of STRO-002 to be Presented at ASCO 2021
Published:
2021-05-19
(Crawled : 21:00)
- sutrobio.com
STRO
M
|
$3.715
-1.46%
120K
|
Health Technology
|
-81.22%
|
O:
1.58%
H:
2.43%
C:
-10.66%
biopharma
phase 1
phase 3
phase 2
Gainers vs Losers
79%
21%
Top 10 Gainers
AGBA
|
News
|
$1.22
205.0%
86M
|
Finance
EGOX
|
$0.0606
68.33%
250M
|
NVFY
|
$3.45
63.51%
20M
|
Consumer Durables
ZCMD
|
$1.98
36.55%
27M
|
Commercial Services
CHRO
|
$1.66
35.51%
70K
|
n/a
INDO
|
$5.43
33.09%
10M
|
Energy Minerals
PAPL
|
$2.07
26.22%
550K
|
RWOD
|
$10.08
26.05%
5.6M
|
n/a
AULT
|
$0.304
25.57%
47M
|
Manufacturing
HUSA
4
|
$2.07
23.95%
2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.